These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 29120535)

  • 1. miRNA profiling identifies deregulated miRNAs associated with osteosarcoma development and time to metastasis in two large cohorts.
    Andersen GB; Knudsen A; Hager H; Hansen LL; Tost J
    Mol Oncol; 2018 Jan; 12(1):114-131. PubMed ID: 29120535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.
    Fenger JM; Roberts RD; Iwenofu OH; Bear MD; Zhang X; Couto JI; Modiano JF; Kisseberth WC; London CA
    BMC Cancer; 2016 Oct; 16(1):784. PubMed ID: 27724924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Machine learning and experimental analyses identified miRNA expression models associated with metastatic osteosarcoma.
    Abedi S; Behmanesh A; Mazhar FN; Bagherifard A; Sami SH; Heidari N; Hossein-Khannazer N; Namazifard S; Kazem Arki M; Shams R; Zarrabi A; Vosough M
    Biochim Biophys Acta Mol Basis Dis; 2024 Oct; 1870(7):167357. PubMed ID: 39033966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A four serum-miRNA panel serves as a potential diagnostic biomarker of osteosarcoma.
    Huang C; Wang Q; Ma S; Sun Y; Vadamootoo AS; Jin C
    Int J Clin Oncol; 2019 Aug; 24(8):976-982. PubMed ID: 31111286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a novel miRNA-target gene regulatory network in osteosarcoma by integrating transcriptome analysis.
    He C; Gao H; Fan X; Wang M; Liu W; Huang W; Yang Y
    Int J Clin Exp Pathol; 2015; 8(7):8348-57. PubMed ID: 26339404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of the osteosarcoma expression phenotype by microRNAs.
    Namløs HM; Meza-Zepeda LA; Barøy T; Østensen IH; Kresse SH; Kuijjer ML; Serra M; Bürger H; Cleton-Jansen AM; Myklebost O
    PLoS One; 2012; 7(10):e48086. PubMed ID: 23133552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
    Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
    Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miRNA profiling in serum and tissue samples to assess noninvasive biomarkers for NSCLC clinical outcome.
    Petriella D; De Summa S; Lacalamita R; Galetta D; Catino A; Logroscino AF; Palumbo O; Carella M; Zito FA; Simone G; Tommasi S
    Tumour Biol; 2016 Apr; 37(4):5503-13. PubMed ID: 26566629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of circulating miR-25-3p as a novel diagnostic and prognostic biomarker in osteosarcoma.
    Fujiwara T; Uotani K; Yoshida A; Morita T; Nezu Y; Kobayashi E; Yoshida A; Uehara T; Omori T; Sugiu K; Komatsubara T; Takeda K; Kunisada T; Kawamura M; Kawai A; Ochiya T; Ozaki T
    Oncotarget; 2017 May; 8(20):33375-33392. PubMed ID: 28380419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of miRNA-gene expression-genomic profiles reveals complex mechanisms of microRNA deregulation in osteosarcoma.
    Maire G; Martin JW; Yoshimoto M; Chilton-MacNeill S; Zielenska M; Squire JA
    Cancer Genet; 2011 Mar; 204(3):138-46. PubMed ID: 21504713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs for osteosarcoma in the mouse: a meta-analysis.
    Chang J; Yao M; Li Y; Zhao D; Hu S; Cui X; Liu G; Shi Q; Wang Y; Yang Y
    Oncotarget; 2016 Dec; 7(51):85650-85674. PubMed ID: 27852052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and molecular characterization of the human osteosarcoma 3AB-OS cancer stem cell line: a possible model for studying osteosarcoma origin and stemness.
    Di Fiore R; Fanale D; Drago-Ferrante R; Chiaradonna F; Giuliano M; De Blasio A; Amodeo V; Corsini LR; Bazan V; Tesoriere G; Vento R; Russo A
    J Cell Physiol; 2013 Jun; 228(6):1189-201. PubMed ID: 23129384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and Validation of a Potent Multi-miRNA Signature for Prediction of Prognosis of Osteosarcoma Patients.
    Luo X; Tang J; Xuan H; Liu J; Li X
    Med Sci Monit; 2020 Feb; 26():e919272. PubMed ID: 32098942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miRNA expression profile in human osteosarcoma: role of miR-1 and miR-133b in proliferation and cell cycle control.
    Novello C; Pazzaglia L; Cingolani C; Conti A; Quattrini I; Manara MC; Tognon M; Picci P; Benassi MS
    Int J Oncol; 2013 Feb; 42(2):667-75. PubMed ID: 23229283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer.
    Krishnan P; Ghosh S; Wang B; Li D; Narasimhan A; Berendt R; Graham K; Mackey JR; Kovalchuk O; Damaraju S
    BMC Genomics; 2015 Sep; 16():735. PubMed ID: 26416693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteosarcoma cell-derived exosomes affect tumor microenvironment by specific packaging of microRNAs.
    Raimondi L; De Luca A; Gallo A; Costa V; Russelli G; Cuscino N; Manno M; Raccosta S; Carina V; Bellavia D; Conigliaro A; Alessandro R; Fini M; Conaldi PG; Giavaresi G
    Carcinogenesis; 2020 Jul; 41(5):666-677. PubMed ID: 31294446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients.
    Torres A; Torres K; Pesci A; Ceccaroni M; Paszkowski T; Cassandrini P; Zamboni G; Maciejewski R
    Int J Cancer; 2013 Apr; 132(7):1633-45. PubMed ID: 22987275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNA expression profile in a large series of bladder tumors: identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer.
    Pignot G; Cizeron-Clairac G; Vacher S; Susini A; Tozlu S; Vieillefond A; Zerbib M; Lidereau R; Debre B; Amsellem-Ouazana D; Bieche I
    Int J Cancer; 2013 Jun; 132(11):2479-91. PubMed ID: 23169479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
    Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
    Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulated Adhesion-Associated microRNAs as Prognostic Predictors in Childhood Osteosarcoma.
    Delsin LEA; Roberto GM; Fedatto PF; Engel EE; Scrideli CA; Tone LG; Brassesco MS
    Pathol Oncol Res; 2019 Jan; 25(1):11-20. PubMed ID: 28944406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.